Form 8-K Valeant Pharmaceuticals For: Apr 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
Go back to Form 8-K Valeant Pharmaceuticals For: Apr 01
April 11, 2016 5:42 PM EDT
In analyzing the latest short interest data for the Specialty Pharmaceutical sector, Guggenheim's Louise Chen notes that Valeant Pharma (NYSE: VRX) short interest rose 56.1% - the largest increase in the sector.
Valeant Pharma short interest was at 18,021,306 shares as of 03/31/2016, versus 11,548,303... More
April 11, 2016 4:28 PM EDT
Valeant Pharma (NYSE: VRX) disclosed the following on Monday:
Item 1.01. Entry Into a Material Definitive Agreement.
On April 11, 2016, Valeant Pharmaceuticals International, Inc. (the Company) entered into an amendment and waiver (Amendment No. 12) to its Third Amended and Restated Credit and Guaranty Agreement, dated as of February 13, 2012 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the Credit Agreement).
Amendment No. 12 extends the deadline for filing (i) the Companys Form 10-K for the fiscal year ended December 31, 2015 to May 31, 2016 and (ii) the Companys Form 10-Q for the... More
